Bioavailability of Seocalcitol (cas 134404-52-7) I: Relating solubility in biorelevant media with oral bioavailability in rats—effect of medium and long chain triglycerides
-
Add time:07/31/2019 Source:sciencedirect.com
Simulated intestinal media (SIM) containing bile salt (BS) and phospholipids (PL) with and without medium chain lipolytic products (MC-LP) or long chain lipolytic products (LC-LP) were developed to study the solubility of Seocalcitol (cas 134404-52-7). Both MC-LP and LC-LP were studied in order to investigate the influence of fatty acid chain length on the in vitro solubility of seocalcitol. The same solubility of seocalcitol was found in media containing either MC-LP or LC-LP. The bioavailability after oral administration of seocalcitol dissolved in medium chain triglyceride (MCT), long chain triglyceride (LCT), and a reference formulation containing propylene glycol (PG) was studied in vivo in rats. The lipid formulations showed a twofold increase in bioavailability compared with the reference formulation, indicating positive effects of lipids on the bioavailability reflecting a better solubility in the intestine and protection against precipitation of seocalcitol in the gastro intestinal tract. There was no difference in the in vivo bioavailability of seocalcitol between the MCT and the LCT solutions, which correlates with the identical in vitro solubility of seocalcitol in SIM containing MC-LP or LC-LP.
We also recommend Trading Suppliers and Manufacturers of Seocalcitol (cas 134404-52-7). Pls Click Website Link as below: cas 134404-52-7 suppliers
Prev:MNU-induced mammary gland carcinogenesis: Chemopreventive and therapeutic effects of vitamin D and Seocalcitol (cas 134404-52-7) on selected regulatory vitamin D receptor pathways
Next:Bioavailability of Seocalcitol (cas 134404-52-7)) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Polyclonal antibodies to EB1089 (Seocalcitol (cas 134404-52-7)), an analog of 1α,25-dihydroxyvitamin D3☆08/05/2019
- A non-calcemic sulfone version of the vitamin D3 analogue Seocalcitol (cas 134404-52-7) (EB 1089): chemical synthesis, biological evaluation and potency enhancement of the anticancer drug adriamycin08/04/2019
- Differential skeletal responses of hindlimb unloaded rats on a vitamin D-deficient diet to 1,25-dihydroxyvitamin D3 and its analog, Seocalcitol (cas 134404-52-7) (EB1089)08/03/2019
- Determination of the vitamin D analog EB 1089 (Seocalcitol (cas 134404-52-7)) in human and pig serum using liquid chromatography–tandem mass spectrometry08/02/2019
- Bioavailability of Seocalcitol (cas 134404-52-7)08/01/2019
- MNU-induced mammary gland carcinogenesis: Chemopreventive and therapeutic effects of vitamin D and Seocalcitol (cas 134404-52-7) on selected regulatory vitamin D receptor pathways07/30/2019


